Language
Search
News
- Bruker and Lawrence Berkeley National Laboratory Collaborate on Novel Technology for Structural...
- Bruker Announces Four Ultra-High Field NMR Orders from the Central European Institute of Technology...
- CMC-assist™, the First NMR Software Tool Enabling the Seamless, Integrated Routine Workflow from...
- MR Newsletter 08/2011
Pharmaceutical Reseach
Toxicology screening using NMR
The later that a molecule or molecular class is lost from the drug development pipeline, the higher the financial cost. Minimizing attrition is therefore one of the most important aims of a pharmaceutical discovery programme. Novel technologies that increase the probability of making the right choice early save resources, and promote safety, efficacy and profitability. Metabolomics is a systems approach for studying in vivo metabolic profiles, which promises to provide information on drug toxicity, disease processes and gene function at several stages in the discovery and-development process.

